My da|ra Login

Detailed view

metadata language: English

Replication data for: The Effect of Medicare Part D on Pharmaceutical Prices and Utilization

Version
V0
Resource Type
Dataset
Creator
  • Duggan, Mark
  • Scott Morton, Fiona
Publication Date
2010-03-01
Description
  • Abstract

    Medicare Part D began coverage of prescription drugs in 2006. Rather than setting pharmaceutical prices, the government contracted with private insurers to provide drug coverage. Theory suggests that additional insured consumers will raise the optimal price of a branded drug, while the insurer's ability to move demand to substitute treatments may lower prices. We estimate the program's effect on the price and utilization of pharmaceutical treatments. We find that Part D enrollees paid substantially lower prices than while uninsured, and increased their utilization of prescription drugs. We find relative price declines only for drugs with significant therapeutic competition. (L18, L11, L65)
Availability
Download
Relations
  • Is supplement to
    DOI: 10.1257/aer.100.1.590 (Text)
Publications
  • Duggan, Mark, and Fiona Scott Morton. “The Effect of Medicare Part D on Pharmaceutical Prices and Utilization.” American Economic Review 100, no. 1 (March 2010): 590–607. https://doi.org/10.1257/aer.100.1.590.
    • ID: 10.1257/aer.100.1.590 (DOI)

Update Metadata: 2020-05-18 | Issue Number: 2 | Registration Date: 2019-10-11

Duggan, Mark; Scott Morton, Fiona (2010): Replication data for: The Effect of Medicare Part D on Pharmaceutical Prices and Utilization. Version: V0. ICPSR - Interuniversity Consortium for Political and Social Research. Dataset. https://doi.org/10.3886/E112338